Kappos, L., De Stefano, N., Freedman, M. S., Cree, B. A., Radue, E., Sprenger, T., . . . Tomic, D. (2016). Inclusion of brain volume loss in a revised measure of 'no evidence of disease activity' (NEDA-4) in relapsing-remitting multiple sclerosis. Multiple sclerosis, 22(10), 1297-1305. https://doi.org/10.1177/1352458515616701
Citácia podle Chicago (17th ed.)Kappos, Ludwig, et al. "Inclusion of Brain Volume Loss in a Revised Measure of 'No Evidence of Disease Activity' (NEDA-4) in Relapsing-remitting Multiple Sclerosis." Multiple Sclerosis 22, no. 10 (2016): 1297-1305. https://doi.org/10.1177/1352458515616701.
Citácia podľa MLA (8th ed.)Kappos, Ludwig, et al. "Inclusion of Brain Volume Loss in a Revised Measure of 'No Evidence of Disease Activity' (NEDA-4) in Relapsing-remitting Multiple Sclerosis." Multiple Sclerosis, vol. 22, no. 10, 2016, pp. 1297-1305, https://doi.org/10.1177/1352458515616701.